Hematology, Oncology and BMT Research and Innovation

Novel Adjuvant Therapy Resolves Steroid-Refractory Acute Graft-Versus-Host Disease in a Pediatric Transplant Recipient

Physicians have successfully treated steroid-refractory gastrointestinal acute graft-versus-host disease with the monoclonal antibody vedolizumab in a pediatric allogeneic hematopoietic cell transplant recipient.

Natural Killer Cells

From Natural Killer Cells to Virus-Specific T Cells: What’s Next in Cellular Therapy

Harnessing the power of the immune system to overcome cancer, improve outcomes of bone marrow transplants and fight viral infections in immunocompromised pediatric patients is at the heart of cell therapy research.

Dr. Jonathan Finlay

Dr. Jonathan Finlay Receives Lifetime Achievement Award from Society for Neuro-Oncology

(COLUMBUS, Ohio) – Jonathan Finlay, MB, ChB, FRCP, program director of Neuro-Oncology at Nationwide Children’s Hospital, has become the first pediatric specialist to receive the Society for Neuro-Oncology’s Lifetime Achievement Award, which may be awarded to anyone connected to

Pediatrics Nationwide

Targeting Alternative RNA Splicing in Pediatric Cancers

Targeting alternative RNA splicing in tumor cells could lead to cancer therapies.

Ohio State, Nationwide Children's Hospital First to Offer 'Flash' Proton Therapy

A highly targeted form of proton therapy – known as “FLASH” – will be investigated in clinical trial participants with certain newly diagnosed, recurrent or advanced cancers as part of central Ohio’s first and only proton therapy center, a collaborative effort of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and Nationwide Children’s Hospital.

Limb-Girdle Muscular Dystrophy Type 2E

Understanding the Role of LSD2 in the Molecular Genetics of Ewing Sarcoma

Study reveals novel potential drug target for Ewing sarcoma.


Profile of a Cancer: Getting to Know Ewing Sarcoma

Understanding how to fight a deadly enemy requires knowledge of its back story, its habits, where it hangs out and how it behaves under pressure. Ewing sarcoma has been called in for questioning.

Region’s First Proton Therapy Facility to Treat Cancer Patients

The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute are collaborating with Nationwide Children’s Hospital to bring the first proton therapy treatment facility to central Ohio. This will offer state-of-the-art radiation oncology treatment for adult and pediatric cancer patients in one place.